News

Alexion Clinical Trial

Alexion is now recruiting for copper and Molybdenum Balance in Participants with Wilson disease treated with ALXN 1840.

Click here for more information, or click here for a brochure about the trial.

By Published On: June 22, 2021Categories: Clinical Trials

Share This Story, Choose Your Platform!